stockrow
Monday 9 November 2026
Export ICCM’s income statement to Excel — free account
IceCure Medical Ltd.
ICCMIceCure Medical Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $3.4 million, up 2.67% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- −2,068.2%
- Free cash flow
- +3.88%
- Total debt
- −64.4%
Quarter to June 2026, against a year earlier
0.68
0.01
−1.45%
Follow ICCM
Alert me
IceCure Medical Ltd. (ICCM) P/E ratio
IceCure Medical Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2026 | 0.0× | — |
| Mar 2025 | 0.0× | — |
| Mar 2024 | 0.0× | — |
| Sep 2023 | 0.0× | — |
| 14 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| ICCM IceCure Medical Ltd. | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| AIDX 20/20 Biolabs Inc. compare | n/m |
| ADGM Adagio Medical Holdings, Inc. compare | n/m |
| IVF INVO Fertility, Inc compare | n/m |
| NUWE Nuwellis, Inc. compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)